Ultomiris 1,100 MG/11 ML vial 11ML
Ended Awarded Last action
- Contract number
- SPE2DR26FXR5R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,252
Award facts
- Contract value 100% obligated
- $28,251.81 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $28,251.81 delivery order by the Defense Logistics Agency on January 22, 2026, for Ultomiris (pegtibicasan alfa) 1,100 mg/11 mL vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 12, 2026, and was competitively awarded without set-aside designation. This award is executed under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
Amerisourcebergen Drug Corp operates as a subsidiary of Cencora, Inc., which rebranded its operations under the parent company name. The award supports the Department of Defense's medical supply chain operations by delivering a specialized pharmaceutical product used in complement-mediated thrombotic microangiopathy treatment. This delivery order reflects the contractor's established capability to fulfill federal medical procurement requirements efficiently across therapeutic domains while meeting the critical healthcare needs of military treatment facilities and veterans' healthcare programs worldwide.
Quick answers
Who was awarded contract SPE2DR26FXR5R?
SPE2DR26FXR5R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FXR5R worth?
The government has obligated $28,252 on SPE2DR26FXR5R.
Is contract SPE2DR26FXR5R an order under another contract?
Yes. SPE2DR26FXR5R is a delivery order under SPE2DR25D6029, an indefinite delivery contract.
Was contract SPE2DR26FXR5R competed?
The extent of competition for SPE2DR26FXR5R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award